Literature DB >> 10735015

Differences in breast cancer prognosis among African-American and Caucasian women.

J J Dignam1.   

Abstract

This review explores factors potentially contributing to the disparity in survival after breast cancer between African-American and Caucasian women in the United States. A number of factors have been implicated as the cause of poorer survival for black women, including clinical and pathologic features of the disease that are indicative of poor prognosis, economic resource inequities, and differences in treatment access and efficacy. The latter is explored in detail using data from the National Surgical Adjuvant Breast and Bowel Project (NSABP), a nationwide multicenter clinical trials group for breast and colorectal cancers. Key studies into the disparity in breast cancer survival are reviewed according to proposed principal determinants of poorer outcome for black women. Results among black and white women participating in several randomized NSABP clinical trials are also presented. Primary endpoints in those studies were clinical and pathologic disease characteristics at study entry, time to disease progression or new cancers, and total survival time after breast cancer diagnosis and treatment. In most studies reported in the literature, the primary explanatory factor alone, such as stage of disease at diagnosis, did not fully account for differences in outcome between groups; when additional factors were taken into account, however, prognoses became more similar. Results from the NSABP clinical trials similarly indicated that when stage of disease and treatment were comparable, outcomes for blacks did not differ markedly from those of whites. In summary, black women, diagnosed at comparable disease stage as white women and treated appropriately, tend to experience similar breast cancer prognoses and survival. However, important clinical and pathologic disease characteristics may continue to place certain women at increased risk of poorer outcome, and warrant continued study. The opportunity for increased clinical trial participation by black women is encouraged.

Entities:  

Mesh:

Year:  2000        PMID: 10735015     DOI: 10.3322/canjclin.50.1.50

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  31 in total

1.  Examination of ancestral informative markers and self-reported race with tumor characteristics of breast cancer among Black and White women.

Authors:  Kerryn W Reding; Christopher S Carlson; Orsalem Kahsai; Christina C Chen; Andrew McDavid; David R Doody; Chu Chen; India Ornelas; Kimberly Lowe; Leslie Bernstein; Linda Weiss; Jill A McDonald; Michael S Simon; Brian Strom; Polly A Marchbanks; Ronald Burkman; Robert Spirtas; Jonathan M Liff; Kathleen E Malone
Journal:  Breast Cancer Res Treat       Date:  2012-05-31       Impact factor: 4.872

2.  Time spent in the United States and breast cancer screening behaviors among ethnically diverse immigrant women: evidence for acculturation?

Authors:  William Michael Brown; Nathan S Consedine; Carol Magai
Journal:  J Immigr Minor Health       Date:  2006-10

3.  Paths to health equity: Local area variation in progress toward eliminating breast cancer mortality disparities, 1990-2009.

Authors:  George Rust; Shun Zhang; Khusdeep Malhotra; Leroy Reese; Luceta McRoy; Peter Baltrus; Lee Caplan; Robert S Levine
Journal:  Cancer       Date:  2015-04-23       Impact factor: 6.860

4.  Re: Racial disparities in cancer survival among randomized clinical trials of the Southwest Oncology Group.

Authors:  Philip S Rosenberg; Idan Menashe; Ismail Jatoi; William F Anderson
Journal:  J Natl Cancer Inst       Date:  2010-01-14       Impact factor: 13.506

5.  Eliminating health disparities through transdisciplinary research, cross-agency collaboration, and public participation.

Authors:  Jamila R Rashid; Robert F Spengler; Robin M Wagner; Cindi Melanson; Elizabeth L Skillen; Robert A Mays; Suzanne Heurtin-Roberts; Judith A Long
Journal:  Am J Public Health       Date:  2009-09-17       Impact factor: 9.308

6.  Experiences and perceptions of medical discrimination among a multiethnic sample of breast cancer patients in the Greater San Francisco Bay Area, California.

Authors:  Thu Quach; Amani Nuru-Jeter; Pagan Morris; Laura Allen; Sarah J Shema; June K Winters; Gem M Le; Scarlett Lin Gomez
Journal:  Am J Public Health       Date:  2012-03-15       Impact factor: 9.308

7.  African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study.

Authors:  Azadeh Stark; Celina G Kleer; Iman Martin; Baffour Awuah; Anthony Nsiah-Asare; Valerie Takyi; Maria Braman; Solomon E Quayson; Richard Zarbo; Max Wicha; Lisa Newman
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

8.  Disparities in breast cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.

Authors:  Jacqueline W Miller; Judith Lee Smith; A Blythe Ryerson; Thomas C Tucker; Claudia Allemani
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

9.  Narrowing racial gaps in breast cancer chemotherapy initiation: the role of the patient-provider relationship.

Authors:  Vanessa B Sheppard; Claudine Isaacs; George Luta; Shawna C Willey; Marc Boisvert; Felicity W K Harper; Karen Smith; Sara Horton; Minetta C Liu; Yvonne Jennings; Fikru Hirpa; Felicia Snead; Jeanne S Mandelblatt
Journal:  Breast Cancer Res Treat       Date:  2013-04-16       Impact factor: 4.872

10.  One more hurdle to increasing mammography screening: pubescent, adolescent, and prior mammography screening experiences.

Authors:  Eileen Thomas; LaToya Usher
Journal:  Womens Health Issues       Date:  2009-08-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.